Tetanus, diphtheria, pertussis vaccination coverage before, during, and after pregnancy — 16 states and New York city, 2011

Morbidity and Mortality Weekly Report

Volumn 64, Issue 19, 2015, Pages 522-526

  Ahluwalia, Indu B ^a   Ding, Helen ^b   D’Angelo, Denise ^a   Shealy, Kristen H ^b   Singleton, James A ^c   Liang, Jennifer ^c   Rosenberg, Kenneth D ^d  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b DB Consulting Group Inc   (United States)

^c NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^d OREGON PUBLIC HEALTH DIVISION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE;

ADULT; DIPHTHERIA; FEMALE; HUMAN; PREGNANCY; STATISTICS AND NUMERICAL DATA; TETANUS; TIME; UNITED STATES; VACCINATION; WHOOPING COUGH; YOUNG ADULT;

ADULT; DIPHTHERIA; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FEMALE; HUMANS; NEW YORK CITY; PREGNANCY; TETANUS; TIME FACTORS; UNITED STATES; VACCINATION; WHOOPING COUGH; YOUNG ADULT;

EID: 84931065778     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Note

References (10)

1. CDC. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months—Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011;60:1424–6.
2. Kretsinger K, Broder KR, Cortese MM, et al. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among healthcare personnel. MMWR Recomm Rep 2006;55(No. RR-17):1–37.
3. CDC. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women—Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep 2013;62:131–5.
4. CDC. Tetanus and pertussis vaccination coverage among adults aged ≥18 years—United States, 1999 and 2008. MMWR Morb Mortal Wkly Rep 2010;59:1302–6.
5. Kharbanda EO, Vazquez-Benitez G, Lipkind H, et al. Receipt of pertussis vaccine during pregnancy across 7 Vaccine Safety Datalink sites. Prev Med 2014;67:316–9.
6. Housey M, Zhang F, Miller C, et al. Vaccination with tetanus, diphtheria, and acellular pertussis vaccine of pregnant women enrolled in Medicaid—Michigan, 2011–2013. MMWR Morb Mortal Wkly Rep 2014;63:839–42.
7. Bödeker B, Walter D, Reiter S, Wichmann O. Cross-sectional study on factors associated with influenza vaccine uptake and pertussis vaccination status among pregnant women in Germany. Vaccine 2014;32:4131–9.
8. Wiley KE, Massey PD, Cooper SC, Wood N, Quinn HE, Leask J. Pregnant women’s intention to take up a post-partum pertussis vaccine, and their willingness to take up the vaccine while pregnant: a cross sectional survey. Vaccine 2013;31:3972–8.
9. Steelfisher GK, Blendon RJ, Bekheit MM, et al. Novel pandemic A (H1N1) influenza vaccination among pregnant women: motivators and barriers. Am J Obstet Gynecol 2011;204(Suppl 1):S116–23.
10. Ding H, Black CL, Ball S, et al. Influenza vaccination coverage among pregnant women—United States, 2013–14 influenza season. MMWR Morb Mortal Wkly Rep 2014;63:816–21.